Fingerprint
Dive into the research topics of 'Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?
Sabira Tahseen, Armand Van Deun, Bouke C. de Jong, Tom Decroo
Research output: Contribution to journal › A1: Web of Science-article › peer-review
33
Downloads
(Pure)